Skip to main content
JAMA Network logoLink to JAMA Network
. 2025 Aug 21;8(8):e2533037. doi: 10.1001/jamanetworkopen.2025.33037

Errors in Table 2

PMCID: PMC12371511  PMID: 40839271

In the Original Investigation titled “Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial,”1 published June 17, 2020, there were missing data and errors in the numbers and percentages of birth weight percentiles in Table 2. In addition, Supplement 3 was added to acknowledge the contributions of nonauthor collaborators. This article has been corrected.1

Reference

  • 1.Pels A, Derks J, Elvan-Taspinar A, et al. ; Dutch STRIDER Trial Group . Maternal sildenafil vs placebo in pregnant women with severe early-onset fetal growth restriction: a randomized clinical trial. JAMA Netw Open. 2020;3(6):e205323. doi: 10.1001/jamanetworkopen.2020.5323 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Network Open are provided here courtesy of American Medical Association

RESOURCES